Oncoinvent ASA: Registration of reverse share split

Oslo, Norway, 20 January 2026: Reference is made to the stock exchange announcement made by Oncoinvent ASA (the "Company") on 8 January 2026 regarding the Company's extraordinary general meeting resolving a reverse share split of the Company's shares in the ratio 100:1. The reverse share split has today been registered with the Norwegian Register of Business Enterprises.

Following the registration, the share capital of the Company is NOK 223,920,600 divided into 4,478,412 shares, each with a nominal value of NOK 50.